Markets:

Overview

News

Currencies

International

Treasuries

XOMA Royalty Corporation - Common Stock (NQ:XOMA)

29.71 -0.21 (-0.70%)

Streaming Delayed Price Updated: 1:39 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about XOMA Royalty Corporation - Common Stock

< Previous 1 2 3 4 5 Next >

XOMA's Return On Capital Employed Overview ↗

November 08, 2021

Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q3 sales of $940.00 thousand. Earnings fell to a loss of $3.35 million, resulting in a 9.17% decrease from last quarter. In Q2,...

Via Benzinga

XOMA's Return On Capital Employed Overview ↗

September 08, 2021

According to Benzinga Pro data, during Q2, XOMA (NASDAQ:XOMA) posted sales of $901.00 thousand. Earnings were up 52.33%, but XOMA still reported an overall loss of $3.06 million....

Via Benzinga

Why Did Wedbush Downgrade Xoma? ↗

September 07, 2021

Wedbush has cut XOMA Corporation (NASDAQ: XOMA) to neutral from outperform and lowered its price target to $22 from $41. Analyst Liana Moussatos notes ...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021 ↗

September 07, 2021

Upgrades BMO Capital upgraded the previous rating for BRP Inc (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 03, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

Recap: XOMA Q2 Earnings ↗

August 05, 2021

Shares of XOMA (NASDAQ:XOMA) were flat after the company reported Q2 results. Quarterly Results Earnings per share increased 12.12% over the past year to ($0.29), which beat...

Via Benzinga

Why XOMA Stock Is Trading Higher Wednesday? ↗

July 28, 2021

XOMA Corporation (NASDAQ: XOMA) stock is trading higher during the morning session on robust volume after the FDA granted an Orphan drug tag to NIS793 for...

Via Benzinga

XOMA Buys Royalty, Milestone Interest In Checkmate's Vidutolimod From Kuros Biosciences ↗

July 15, 2021

XOMA Corporation (NASDAQ: XOMA) has acquired the royalty interest position Kuros Biosciences holds in Checkmate Pharmaceuticals Inc's (NASDAQ:...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2021 ↗

June 29, 2021

Upgrades For Nutrien Ltd (NYSE:

Via Benzinga

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

58 Biggest Movers From Yesterday ↗

June 30, 2021

Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors....

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.